Big cap premarket losers led by NVS headlines
Premarket: NVS -13% after Phase 3 drug-failure headlines; Dyn -25%, IONS -10%, SRPT -9%, BIDU -7.5%, RPRX -6%, AMGN -5.5%, and PTON -4.5% also fall.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.